or Try an Advanced Search...

    Technical Analysis for ARQT - Arcutis Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    B 9.56 2.80% 0.26
    ARQT closed up 2.8 percent on Monday, July 1, 2024, on 73 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical ARQT trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Stochastic Sell Signal Bearish 2.80%
    Wide Bands Range Expansion 2.80%
    Overbought Stochastic Strength 2.80%
    Wide Bands Range Expansion 1.49%
    Overbought Stochastic Strength 1.49%
    Stochastic Reached Overbought Strength 2.91%
    Overbought Stochastic Strength 2.91%
    Upper Bollinger Band Touch Strength 2.91%
    Older End-of-Day Signals for ARQT ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above Previous Day's High about 10 hours ago
    Up 3% about 10 hours ago
    Up 2% about 11 hours ago
    Down 1% about 11 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ARQT Chart by TradingView
    Basic chart:

    Profile

    Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunology Organ Systems Autoimmune Disease Psoriasis Atopic Dermatitis Dermatitis Type I Hypersensitivity Atopy Eczema Alopecia Areata Dermatological Diseases Plaque Psoriasis Vitiligo

    Is ARQT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
    Jun 26 AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
    Jun 24 FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
    Jun 20 Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Jun 18 OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
    Jun 17 Has Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?
    Jun 14 Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 99.89%: Read This Before Placing a Bet
    Jun 13 Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
    Jun 13 FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
    Jun 12 Summit (SMMT) Stock Surges 57% in the Past Month: Here's Why
    See more ARQT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.17
    52 Week Low 1.76
    Average Volume 2,991,562
    200-Day Moving Average 6.39
    50-Day Moving Average 8.58
    20-Day Moving Average 8.46
    10-Day Moving Average 8.89
    Average True Range 0.67
    RSI (14) 59.18
    ADX 19.26
    +DI 30.51
    -DI 15.33
    Chandelier Exit (Long, 3 ATRs) 7.84
    Chandelier Exit (Short, 3 ATRs) 9.00
    Upper Bollinger Bands 9.91
    Lower Bollinger Band 7.01
    Percent B (%b) 0.88
    BandWidth 34.28
    MACD Line 0.21
    MACD Signal Line 0.04
    MACD Histogram 0.1694
    Fundamentals Value
    Market Cap 925.34 Million
    Num Shares 96.8 Million
    EPS -4.33
    Price-to-Earnings (P/E) Ratio -2.21
    Price-to-Sales 13.14
    Price-to-Book 13.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.49
    Resistance 3 (R3) 10.45 10.09 10.34
    Resistance 2 (R2) 10.09 9.86 10.12 10.28
    Resistance 1 (R1) 9.83 9.71 9.96 9.87 10.23
    Pivot Point 9.47 9.47 9.54 9.50 9.47
    Support 1 (S1) 9.21 9.24 9.34 9.25 8.89
    Support 2 (S2) 8.85 9.09 8.88 8.84
    Support 3 (S3) 8.59 8.85 8.79
    Support 4 (S4) 8.63